Skin cancer screening and primary prevention: Facts and controversies

Clinics in Dermatology

Volumn 31, Issue 6, 2013, Pages 666-670

  Federman, Daniel G ^a   Kirsner, Robert S ^b   Viola, Kate V ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

AGE; ARTICLE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; COUNSELING; HEALTH CARE COST; HUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; QUALITY OF LIFE; RADIATION EXPOSURE; RADIATION HAZARD; SECONDARY PREVENTION; SKIN CANCER; SUN EXPOSURE; TELEDERMATOLOGY; ULTRAVIOLET RADIATION;

DIRECTIVE COUNSELING; EARLY DETECTION OF CANCER; HUMANS; PRIMARY PREVENTION; SECONDARY PREVENTION; SKIN NEOPLASMS; TELEMEDICINE;

EID: 84886082343     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2013.05.002     Document Type: Article

References (51)

1. Rager E.L., Bridgeford E.P., Ollila D.W. Cutanoeus melanoma: update on prevention, screening, diagnosis, and treatment. Am Fam Physician 2005, 72:269-276.
2. Garner K.L., Rodney W.M. Basal and squamous cell carcinoma. Prim Care 2000, 27:447-458.
3. Jemal A., Clegg L.X., Ward E., et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004, 101:3-27.
4. Siegal R., Ward E., Brawley O., Jemal A. Cancer statistics 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61:212-236.
5. Han J., Colditz G.A., Hunter D.J. Risk factors for skin cancers: a nested case-control study with the Nurses' Health Study. Int J Epidemiol 2006, 35:1514-1521.
6. Available at: Accessed December 30, 2011. http://www.freedomcurrent.com/trendingnews/melanoma-skin-cancer-costs-u-s-economy-8-billion-a-year.html.
7. Yabroff K.R., Bradley C.J., Mariotto A.B., Brown M.L., Feuer E.J. Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst 2008, 100:1755-1762.
8. Chen J.G., Fleischer A.B., Smith E.D., et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 2001, 27:1035-1038.
9. Green A., Williams G., Neale R., et al. Daily sunscreen application and beta carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial. Lancet 1999, 354:723-729.
10. Van de Pols J.C., Williams G.M., Pandeya N., Logan V., Green A.C. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006, 15:2546-2548.
11. Green A.C., Williams G.M., Logan V., Strutton G.M. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2010, 29:257-263.
12. Lin J.S., Elder M., Weinmann S. Behavioral counseling to prevent skin cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2011, 154:190-201.
13. Helfand M., Krages K.P. Counseling to Prevent Skin Cancer: A Summary of the Evidence. (AHRQ Pub No. 03-521b) 2003, Agency for Healthcare Research and Quality, Rockville, MD.
14. Kirsner R.S., Federman D.G. The rationale for skin cancer screening and prevention. Am J Manag Care 1998, 4:1279-1284.
15. Geller A.C., Oliveria S.A., Bishop M., Buckminster M., Brooks K.R., Halpern A.C. Study of health outcomes in school children: key challenges and lessons learned from the Framingham Schools' Natural History of nevi Study. J Sch Health 2007, 77:312-318.
16. Wang S.Q., Dusza S.W. Assessment of sunscreen knowledge: a pilot survey. Br J Dermatol 2009, 161(Suppl 3):28-32.
17. Stechschulte S.A., Kirsner R.S., Federman D.G. Sunscreens for non-dermatologists: what you should know when counseling patients. Postgrad Med 2011, 123:1-8.
18. Sambandan D.R., Ratner D. Sunscreens: an overview and update. J Am Acad Dermatol 2011, 64:748-758.
19. U.S.Preventive Services Task Force. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 150:188-193.
20. Woff T., Tai E., Miller T. Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 150:194-198.
21. Federman D.G., Concato J. Screening for skin cancer: absence of evidence. Arch Dermatol 2009, 145:926-927.
22. Geller A.C., Miller D.R., Swetter S.M., Demierre M.F., Gilchrest B.A. A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol 2006, 142:504-507.
23. Berwick M., Armstropng B.K., Ben-Porat L., et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005, 97:195-199.
24. Elwood J.M. Screening for melanoma and options for its evaluation. J Med Screen 1994, 1:22-38.
25. Aitken J.F., Elwood J.M., Lowe J.B., Firman D.W., Balanda K.P., Ring I.T. A randomized trial of population screening for melanoma. J Med Screen 2002, 9:33-37.
26. Federman D.G., Kravetz J.D., Tobin D.G., Ma F., Kirsner R.S. Full body skin examinations: the patient's perspective. Arch Dermatol 2004, 140:530-534.
27. Federman D.G., Kravetz J.D., Ma F., Kirsner R.S. Patient gender affects skin cancer screening practices and attitudes among veterans. South Med J 2008, 101:513-518.
28. Rodriguez G.L., Ma F., Federman D.G., et al. Predictors of skin cancer screening practice and attitudes in primary care. J Am Acad Dermatol 2007, 57:775-781.
29. Federman D.G., Reid C., Feldman S.R., Greenhoe J., Kirsner R.S. The primary care provider and the care of skin disease. Arch Dermatol 2001, 137:25-39.
30. Roetzheim R.G., Pal N., Van Durme D.J., et al. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol 2000, 43:211-218.
31. Eide M.J., Weinstock M.A., Clark M.A. The association of physician-specialty density and melanoma prognosis in the United States, 1988 to 1993. J Am Acad Dermatol 2009, 60:51-58.
32. Kantor J., Kantor D.E. Routine dermatologist-performed full-body skin examination and early melanoma detection. Arch Dermatol 2009, 45:873-876.
33. Geller A.C., Elwood M., Swetter S.M., et al. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia. Cancer 2009, 115:1318-1327.
34. van der Rhee J.I., Bergman W., Kukutsch N.A. The impact of dermoscopy on the management of pigmented lesions in everyday clinical practice of general dermatologists: a prospective study. Br J Dermatol 2010, 162:563-567.
35. Campose-do-Carmo G., Ramos-e-Silva M. Dermoscopy: basic concepts. Int J Dermatol 2008, 47:712-719.
36. Oliveria S.A., Heneghan M.K., Cushman L.F., Ughetta E.A., Halpern A.C. Skin cancer screening by dermatologists, family practitioners, and internists: barriers and facilitators. Arch Dermatol 2011, 147:39-44.
37. Kirsner R.S., Muhkerjee S., Federman D.G. Skin cancer screening in primary care: prevalence and barriers. J Am Acad Dermatol 1999, 41:564-566.
38. Oliveria S.A., Christos P.J., Marghoob A.A., Halpern A.C. Skin cancer screening and prevention in the primary care setting: national ambulatory medical care survey 1997. J Gen Intern Med 2001, 16:297-301.
39. Federman D.G., Kravetz J.D., Kirsner R.S. Skin cancer screening by dermatologists: prevalence and barriers. J Am Acad Dermatol 2002, 46:710-714.
40. Argenziano G., Zalaudek I., Hofmann-Wellenhof R., et al. Total body skin examinations for skin cancer screening in patients with focused symptoms. J Am Acad Dermatol 2012, 66:212-219.
41. Tsang M.W., Resneck J.S. Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists. J Am Acad Dermatol 2006, 55:54-58.
42. Federman D.G., Kirsner R.S. The primary care physician and the treatment of patients with skin disorders. Dermatology Clinics. 2000, 18:215-221.
43. Chen S.C., Pennie M.L., Kolm P., et al. Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med 2006, 21:678-682.
44. Goulart J.M., Quigley E.A., Dusza S., et al. Skin cancer education for primary care physicians: a systematic review of published evaluated interventions. J Gen Intern Med 2011, 26:1027-1035.
45. Mandelblatt J., Saha S., Teutsch S., et al. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the US Preventive Services Task Force. Ann Intern Med 2003, 139:835-842.
46. Weinstein M.C., Goldie S.J., Losina E., et al. Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness. Ann Intern Med 2001, 134:440-450.
47. Goldman L. Cost-effectiveness in a flat world: can ICDs help the United States get rhythm?. N Engl J Med 2005, 353:1513-1515.
48. Ubel P.A., Hirth R.A., Chernew M.E., et al. What is the price of life and why doesn't it increase at the rate of inflation?. Arch Intern Med 2003, 163:1637-1641.
49. Losina E., Walensky R.P., Geller A., et al. Visual screening for malignant melanoma: a cost effectiveness analysis. Arch Dermatol 2007, 143:21-28.
50. Warshaw E.M., Hillman Y.J., Greer N.L., et al. Teledermatolgy for diagnosis and management of skin conditions: a systematic review. J Am Acad Dermatol 2011, 64:759-772.
51. Viola K.V., Tolpinrud W.L., Gross C.P., Kirsner R.S., Imaeda S., Federman D.G. Outcomes of referral to dermatology for suspicious lesions: implications for teledermatology. Arch Dermatol 2011, 147:556-560.